Pharmaceutical Services Negotiating Committee (PSNC) - News updates


Regulatory updates to support pandemic response

Updates have been made to the Pharmaceutical Services (Advanced and Enhanced Services and Emergency Declaration) Directions 2020 to support developments in the response to the COVID-19 pandemic. Firstly, the declaration of an emergency requiring the flexible provision of pharmaceutical services, which was introduced to help maintain pharmacy services during the COVID-19 outbreak, has been further...

Retrospective price adjustment for Priadel tablets – November 2020

Further to our previous news story relating to the continued supply of Priadel 200mg and 400mg tablets, the Competition and Markets Authority (CMA) have announced that Essential Pharma and the Department for Health and Social Care (DHSC) have agreed on a revised price for Priadel tablets. The new prices were effective from the 5 November...

Reminder – Contractor guidance on the suspension of patient signatures on prescription forms

PSNC has published updated guidance on the dispensing and end of month submission process following the temporary suspension of the requirement for patients (or their representatives) to sign the back of NHS prescription forms or EPS tokens. As part of the social distancing measures to limit the spread of the coronavirus and to assist in...

Reminder: Pandemic Delivery Service ends next Thursday

Pharmacy contractors are reminded that the Pandemic Delivery Service is commissioned until Thursday 3rd December 2020; deliveries to shielded patients can continue to be made under the service until the end of that day. This follows the end of the national lockdown on 2nd December 2020, when clinically extremely vulnerable patients will no longer be...

Class 2 Medicines Recall: Largactil 50mg/2ml solution for injection Aventis Pharma Ltd (trading as Sanofi)

Class 2 MHRA medicines recall – Largactil 50mg/2ml solution for injection Aventis Pharma Ltd (trading as Sanofi) PL 04425/0582 Betahistine dihydrochloride 16mg Tablets (Kent Pharmaceuticals Ltd) PL 30464/0020 Drug alert number: EL (20)A/56 Date issued: 26 November 2020 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Largactil...

Register now to use Real Time Exemption Checking (RTEC)

Real Time Exemption Checking (RTEC) allows pharmacy teams to digitally check if their patients are eligible for free NHS prescriptions because they hold specific exemptions. Pharmacies already using RTEC report that it saves staff time and because a patient that is found to be exempt via RTEC does not need to complete an exemption declaration...

PSNC seeks to address workload pressures during second wave

PSNC has today published an update on the action points that we have been discussing with the NHS and Government to address contractor workload and staffing pressures during the second wave of the COVID-19 pandemic. We have been highlighting the many operational pressures on pharmacy businesses throughout the pandemic and in recent months we have...

COVID-19 Second Wave – PSNC Negotiations Action List (November 2020)

This briefing outlines the scope of urgent discussions that are ongoing between PSNC, the Department of Health and Social Care (DHSC), and NHS England & NHS Improvement (NHSE&I) to ensure that community pharmacy teams have the support they need during the second wave of the COVID-19 pandemic. PSNC has some clear asks, some of which...

27 Products added to the Discount Not Deducted (DND) list

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 27 new products will enter the list of ‘Drugs for which Discount is Not Deducted’ (DND) in Part II of the Drug Tariff from 1 December 2020. This follows the recent announcement...

Class 2 Medicines Recall: Betahistine dihydrochloride 8mg and 16mg tablets (Kent Pharmaceuticals Ltd)

Class 2 MHRA medicines recall – Betahistine dihydrochloride 8mg Tablets (Kent Pharmaceuticals Ltd) PL 30464/0019 Betahistine dihydrochloride 16mg Tablets (Kent Pharmaceuticals Ltd) PL 30464/0020 Drug alert number: EL (20)A/55 Date issued: 26 November 2020 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Betahistine dihydrochloride 8mg Tablets (Kent...